celecoxib actavis hart hylki 200 mg
actavis group ptc ehf. - celecoxibum inn - hart hylki - 200 mg
valsartan jubilant filmuhúðuð tafla 80 mg
jubilant pharmaceuticals nv - valsartanum inn - filmuhúðuð tafla - 80 mg
celecoxib actavis hart hylki 100 mg
actavis group ptc ehf. - celecoxibum inn - hart hylki - 100 mg
valsartan jubilant filmuhúðuð tafla 160 mg
jubilant pharmaceuticals nv - valsartanum inn - filmuhúðuð tafla - 160 mg
valpress filmuhúðuð tafla 160 mg
teva b.v.* - valsartanum inn - filmuhúðuð tafla - 160 mg
valpress filmuhúðuð tafla 80 mg
teva b.v.* - valsartanum inn - filmuhúðuð tafla - 80 mg
delstrigo
merck sharp & dohme b.v. - doravirine, áhrif, nýrnastarfsemi disoproxil fúmarat - hiv sýkingar - veirueyðandi lyf til meðferðar á hiv sýkingum, samsetningum - delstrigo er ætlað fyrir meðferð fullorðnir með hiv 1 án fortíðinni eða sannanir á andstöðu við nnrti flokki, áhrif, eða nýrnastarfsemi. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.
pifeltro
merck sharp & dohme b.v. - doravirine - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.
celebra hart hylki 100 mg
upjohn eesv - celecoxibum inn - hart hylki - 100 mg
celebra hart hylki 200 mg
upjohn eesv - celecoxibum inn - hart hylki - 200 mg